molecular subtypes in diffuse large b-cell lymphoma
Published 9 years ago • 622 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
3:04
applying molecular understanding of dlbcl to management strategies
-
3:04
future directions for the treatment of diffuse large b-cell lymphoma
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
2:29
the management of dlbcl and the importance of characterizing molecular subtypes
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
21:38
drawing the line: the rationale behind blood tube collection order
-
9:08
cbc report || how we can diagnose a blood cancer from cbc report in urdu/hindi
-
0:37
the importance of diagnosing dlbcl on a molecular level and how it will improve treatment
-
1:32
subgroup classification in dlbcl: barriers and considerations
-
2:03
the next generation of novel agents in development for aggressive b-cell lymphoma
-
2:27
elucidating the genetic and molecular basis of dlbcl
-
1:34
molecular-guided treatment of b-cell lymphomas
-
7:16
changes in the classification of dlbcl
-
1:21
cd20/cd3 bispecific antibodies in r/r dlbcl: glofitamab and epcoritamab
-
6:23
molecular classification, biology-based clinical trials and liquid biopsy in lymphoma
-
3:48
non-invasive lymphoma classification using cell-free dna profiling to infer gene expression
-
2:56
molecular subtypes of all: coming to a consensus
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
1:42
precision medicine for b-cell lymphomas
-
1:15
personalized medicine for dlbcl
-
1:02
the changing standard of care in dlbcl